Mark Cuban’s Bid to Disrupt the Drug Supply Chain
October 27, 2022
(Axios) – If you want to understand why lowering retail drug prices can be so difficult, look no further than billionaire investor Mark Cuban’s online pharmacy. What’s happening: Cost Plus Drugs launched in January in a bid to offer transparent, lower drug prices. Cost Plus’ direct-to-consumer model marks up drugs from cost by 15%, plus a $3 pharmacy fee, cutting wholesalers, PBMs, pharmacies and insurers out of the equation. (Read More)